Streetbeat News

Regulatory

CAH

CVS

RADCQ

TGT

The FDA has issued a warning against the use of certain over-the-counter eye drop products due to potential risk of eye infections. The brands associated with this warning include CVS Health Corporation, Cardinal Health, Inc., Rite Aid Corp., and Target Corporation. The FDA has recommended that the manufacturer recall all batches of the affected products. Major retail chains have begun removing the implicated products from their shelves and online platforms.

Portfolio Pulse from Nabaparna Bhattacharya

October 28, 2023 | 4:49 pm

BTCUSD

LINKUSD

PEPEUSD

Bitcoin's 14% gain this week, coupled with Nasdaq's slump, suggests a shift in the tech investment landscape, according to Charlie Morris, founder of ByteTree. He advises tech investors to 'jump ship'. The CoinDesk Market Index and Computing Sector also saw increases, driven by Chainlink and Fetch.AI tokens. The poor performance of U.S. stocks compared to Bitcoin's rise is significant. There is optimism that a regular Bitcoin investment fund will get regulatory approval soon.

Portfolio Pulse from Ananya Gairola

October 28, 2023 | 4:36 am

BPTS

Biophytis SA (NASDAQ CM:BPTS) has received a notice of delisting from Nasdaq due to non-compliance with the minimum $2,500,000 stockholders' equity requirement. The company intends to request a hearing before the Nasdaq Hearings Panel to present its plan for regaining and sustaining compliance.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 9:30 pm

DHAC

Digital Health Acquisition Corp. (NASDAQ:DHAC) has received approval from Nasdaq to transfer its securities listing from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer, effective from October 30, 2023, will resolve the company's previously disclosed deficiencies in meeting the Nasdaq Global Market's continued listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 9:29 pm

LMDX

LumiraDx Limited (NASDAQ:LMDX) has received a notice from the Nasdaq Stock Market stating that its securities are subject to delisting due to non-compliance with the Minimum Bid Price Requirement. The company has not regained compliance within the provided 180 days. LumiraDx intends to appeal the delisting determination and is working on a plan to regain compliance.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 9:29 pm

ALGN

AMZN

DIA

GOOGL

PDD

QQQ

SPY

TLT

WHR

The stock market experienced volatility due to fears of a wider Middle East conflict and a cautious Q4 earnings outlook. The US economy exceeded expectations with a Q3 growth rate of 4.9%, driven by strong consumer spending. Bitcoin rallied as ETF approval nears. Major US companies beat Q3 earnings estimates but warned of a Q4 slowdown. Amazon emerged as the top performer among tech titans, while Alphabet had a tough week due to disappointing cloud business performance. The SPDR S&P 500 ETF Trust, Invesco QQQ Trust, and Dow Jones Industrial Average ETF fell, while the iShares 20+ Year Treasury Bond ETF rose. Chinese-based stocks PDD Holdings and JD.com were the top performers within the Nasdaq 100.

Portfolio Pulse from Piero Cingari

October 27, 2023 | 8:34 pm

EQIX

Equinix Inc has filed for a mixed shelf offering with the SEC, although the size of the offering has not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:31 pm

JNJ

Johnson & Johnson (JNJ) has stated in an SEC filing that the financial impact of the conflict in Israel during Q3 was not material. The company also noted that the long-term implications of the conflict are difficult to predict at this time.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:30 pm

TUP

Tupperware Brands Corp has announced that it will likely be further delayed in filing its 2023 quarterly reports on Form 10-Q and annual report on Form 10-K for FY23, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:28 pm

CHRS

Coherus Biosciences is expected to pay a $25M milestone to Shanghai Junshi Biosciences in March 2024, as per an agreement dated Feb 1, 2021, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:27 pm